Navigation Links
China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
Date:9/7/2010

China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC -- BOSTON, Sept. 7 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Pharmaceuticals Click to view news release full screen  

China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC

 

BOSTON, Sept. 7 /PRNewswire/ -- China PharmaHub Corp. (OTC Bulletin Board: CPHB) ("PharmaHub"), which recently merged with World Wide Relics (OTC Bulletin Board: WRLC) and, effective August 23, 2010, changed its name from World Wide Relics, Inc. to China PharmaHub Corp., announced today that effective Tuesday, September 7, 2010, its stock shall begin trading under the symbol "CPHB."  The change has been announced in FINRA's Daily List for September 3, 2010 to be effective September 7, 2010.  

(Logo: http://photos.prnewswire.com/prnh/20100907/LA60053LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20100907/LA60053LOGO)

The purpose of the name change is to better reflect PharmaHub's goals of becoming a global pharmaceutical HUB that specializes in the identification, licensing, development and commercialization of pharmaceutical and healthcare products and technologies that its management believes could make a significant difference to patients and society worldwide. PharmaHub's corporate goal is to create maximum value from existing intellectual properties and technologies of its global partners by utilizing its broad-base of knowledge, understanding and resource allocation ability in the pharmaceutical and healthcare industries.

Richard Lui, CEO of PharmaHub stated, "We are thrilled to being trading under a symbol which better reflects our corporate goals and also reflects the name under which we were originally founded.  Since founding, we have been forming relationships with and have built what we believe is a strong foundation of strategic alliances, partnerships and joint ventures.  We believe that our new trading symbol reflects the progress we have made in becoming a solid bridge between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the U.S. and Europe.  

About PharmaHub:China PharmaHub Corp. is engaged in the business of licensing, developing and the commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide, with initial emphasis in the United States and Europe. Management believes that PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality.  PharmaHub's corporate headquarters are located in California, with offices in Boston and China. For more information visit www.chnpharmahub.com.

Forward-Looking StatementsThis press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein. Contact:Contact:Monica DingChief Financial OfficerTel:  (909)843-6388 Cell: (626) 589-5136Email: ir@chnpharmahub.com
'/>"/>

SOURCE China PharmaHub Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Sky One Medical Updates Financial Guidance for 2010
2. China-Biotics Announces September 20 Investor Day Schedule
3. China Cord Blood Corporation to Announce First Quarter Fiscal 2011 Financial Results
4. Wise Sky Highlights Their Disappointment at Emergents Decision Not to Enter the China Market
5. Reportlinker Adds The Market for Medical Devices in Brazil, Russia, India & China
6. Reportlinker Adds The Market for Pharmaceuticals in Brazil, Russia, India & China
7. China-Biotics to Host Investor Day in Shanghai to Discuss Corporate Development Strategy
8. BMP Sunstones Hao Wawa (Good Baby) Brand Ranked First Among Chinas Top Three Pediatric Medicine Brands
9. UPDATE: China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
10. China PharmaHub Corp. Introduces a Magic Bullet Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh
11. Reportlinker Adds Pharmaceutical M&A in the Asia-Pacific Region - India and China drive regional activity but Japan still dominates high value transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition of the ... their offering. ... The ablation device global market is expected to grow at high ... Ablation is the minimally invasive therapeutic tissue excision procedure used ... removal, to the removal of abnormally conducting cardiac tissue in atrial ...
(Date:3/29/2017)... SAN FRANCISCO , March 29, 2017 /PRNewswire/ ... an option agreement with Bionure Farma, S.L. for ... BN201 and to BN119 in the field of ... million plus sales-based royalties. The agreement provides ... stage assets with a differentiated product profile. Under ...
(Date:3/29/2017)... 29, 2017   Royal Philips (NYSE: ... technology, and PathAI, a company that develops artificial ... aim to develop solutions that improve the precision ... other diseases. The partnership aims to build deep ... of artificial intelligence to be applied to massive ...
Breaking Medicine Technology:
(Date:3/29/2017)... , ... March 29, 2017 , ... Immunotherapy has emerged ... number of cancers and is touted to be the next revolution in our fight ... has been in the form of immune checkpoint inhibitors such as PD-1 and PD-L1 ...
(Date:3/29/2017)... PA (PRWEB) , ... March 29, 2017 , ... The ... W’80, WG’81, and Julie Taffet Moelis, W’81, have made a $10 million gift to ... deferred admission opportunity that will provide a pathway to a Wharton MBA for highly-qualified ...
(Date:3/28/2017)... ... ... Tuesday, March 28, 2017, is the annual American Diabetes Association Alert Day, ... find out if they are at risk for developing Type 2 diabetes. In recognition ... by programming the LAX pylons the color red. Downtown’s U.S. Bank Tower Crown Lights ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
Breaking Medicine News(10 mins):